Review
Accepted on 19 Jan 2024
Plasmablastic Lymphoma: Current Knowledge and Future Directions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1354604
Type at least 3 characters
5,330 articles
Articles
Case Report
Accepted on 19 Jan 2024
Combination Treatment with Anti-HER2 Therapeutic Antibody RC48,PD-1 Inhibitor, Radiotherapy, and Granulocyte Macrophage-Colony Stimulating factor(GM-CSF) in Patient with Metastatic Gastric Cancer: A Case Report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1321946
Review
Accepted on 19 Jan 2024
Immune Checkpoint Inhibitors Associated Cardiovascular Immune-Related Adverse Events Author
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1340373
Review
Accepted on 19 Jan 2024
Forces at play: Exploring non-cytokine factors in affecting the cancer metastasis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1274474
Original Research
Accepted on 19 Jan 2024
Chimeric antigen receptor (CAR) T cells targeting the GM3(Neu5Gc) ganglioside
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1331345
Mini Review
Published on 19 Jan 2024
The role of IL-36 and 37 in hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1281121
Brief Research Report
Published on 19 Jan 2024
Optimal dosage protocols for mathematical models of synergy of chemo- and immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1303814
Original Research
Published on 19 Jan 2024
Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1295693
Review
Published on 19 Jan 2024
Surprising magic of CD24 beyond cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1334922
Original Research
Published on 19 Jan 2024
Platinum desensitization therapy and its impact on the prognosis of ovary high-grade serous adenocarcinoma: a real world-data
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1346464
Original Research
Published on 19 Jan 2024
Development and verification of a combined immune- and cancer-associated fibroblast related prognostic signature for colon adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1291938
Original Research
Published on 19 Jan 2024
Effect of sodium stibogluconate in recruiting and awakening immune cells in the pleural fluid of pancreatic cancer: preparation for immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1315468
Review
Accepted on 18 Jan 2024
Gut microbiota and dietary intervention: affecting immunotherapy efficacy in non-small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1343450
Review
Accepted on 18 Jan 2024
MUC1 and MUC16: Critical for Immune Modulation in Cancer Therapeutics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1356913
Original Research
Accepted on 18 Jan 2024
Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transformation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1323319
Review
Accepted on 18 Jan 2024
A Review of Natural Products Targeting Tumor Immune Microenvironments for the Treatment of Lung Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1343316